Drug Search Results
More Filters [+]

Teprenone

Alternative Names: teprenone, geranylgeranylacetone, selbex
Latest Update: 2024-10-01
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PG Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Colombia | Dominican Republic | Jordan | Korea | Pakistan

Approved Indications: None

Known Adverse Events: None

Company: Guowei Pharmaceutical
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Teprenone

Countries in Clinic: China

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Gastritis

Phase 1: Edema|Flushing

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20222548

P1

Completed

Gastritis|Flushing|Edema

2022-11-10

CTR20130427

P2

Active, not recruiting

Gastritis

None

Recent News Events